Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
BR.2.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-3779.06China
BR.2.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BQ.1.1.79ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BQ.1.1.79ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BQ.1.1.79ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BQ.1.1.79NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BQ.1.14ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BQ.1.14ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BQ.1.14ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BQ.1.14NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
FD.4ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
FD.4ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
FD.4ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FD.4NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
CM.7ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
CM.7ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
CM.7ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
CM.7NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BQ.1.25.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BQ.1.25.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BQ.1.25.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BQ.1.25.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BQ.1.13.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BQ.1.13.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BQ.1.13.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BQ.1.13.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
XBC.1.4ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
XBC.1.4ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBC.1.4ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBC.1.4NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
GC.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
GC.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
GC.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
GC.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
XBB.1.5.40ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
XBB.1.5.40ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.1.5.40ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.5.40NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BQ.1.1.5ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BQ.1.1.5ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BQ.1.1.5ENiu-ECACGTTAACAATATTGCAGC20402639126372R-3779.86China
BQ.1.1.5NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
FL.18.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
FL.18.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
FL.18.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FL.18.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
FL.15ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
FL.15ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
FL.15ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FL.15NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used